REVIEW OF REIMBURSEMENT DECISION DRIVERS FOR RARE CANCER THERAPIES ACROSS EU5 MARKETS

被引：0
|
作者：
Gupta, J. [1 ]
Wahal, V. P. [2 ]
机构：
[1] DRG Abacus, Gurgaon, India
[2] DRG Market Access Insights, Gurgaon, India
来源：
VALUE IN HEALTH | 2017年 / 20卷 / 09期
关键词：
D O I：
10.1016/j.jval.2017.08.965
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PSY138
引用
收藏
页码：A569 / A569
页数：1
相关论文
共 50 条
  • [41] MARKET ACCESS TRENDS ACROSS THE EU5 AND US: 2009 TO 2018-AN UPDATE
    Mycka, J.
    Lobb, W.
    Dellamano, R.
    Dalal, N.
    Dellamano, L.
    Pereira, E.
    Mora, M.
    Pollere, D.
    Papa, R.
    VALUE IN HEALTH, 2019, 22 : S300 - S300
  • [42] WHAT IS THE REGULATORY AND HTA LANDSCAPE OF NON-SMALL CELL LUNG CANCER DRUGS ACROSS THE EU5 COUNTRIES?
    Inumerable, R. V. F.
    Rubinstein, J.
    Lurie, B. F.
    Guill, E. W.
    VALUE IN HEALTH, 2019, 22 : S508 - S508
  • [43] ENSURING THAT PHASE III PROGRAMS ARE DESIGNED TO MEET THE EVOLVING HTA REQUIREMENTS ACROSS THE EU5
    Lucas, F.
    Secker-johnson, R.
    VALUE IN HEALTH, 2012, 15 (07) : A312 - A312
  • [44] INCIDENCE OF GERMLINE BRCA 1 AND 2 MUTATED BREAST CANCER IN THE EU5
    Kim, R. S.
    Peterson, A.
    Isherwood, A.
    Uppal, H.
    Barlev, A.
    VALUE IN HEALTH, 2016, 19 (07) : A715 - A715
  • [45] GAUGING THE ROLE OF HTA IN REIMBURSEMENT DECISION-MAKING ACROSS FIVE MARKETS IN LATIN AMERICA
    Dummett, H.
    Kirpekar, S.
    Shankland, B.
    VALUE IN HEALTH, 2011, 14 (07) : A555 - A555
  • [46] EFFECT OF PATIENT INVOLVEMENT IN TREATMENT DECISION MAKING ON DISEASE OUTCOMES IN RHEUMATOID ARTHRITIS IN THE EU5
    Karki, C.
    Panchal, S.
    Baynton, E.
    Shah-Manek, B.
    VALUE IN HEALTH, 2018, 21 : S260 - S260
  • [47] COMPARISON OF DISEASE AGNOSTIC HEALTHCARE RESOURCE UTILIZATION AND COSTS ACROSS THE US AND EU5 POPULATION
    Silber, A.
    Oak, B.
    Kulkarni, A.
    Goswami, L.
    Kataria, D.
    O'Hara, M.
    Hadker, N.
    VALUE IN HEALTH, 2023, 26 (12) : S138 - S138
  • [48] ASSESSING THE REAL WORLD USAGE OF PD-1 INHIBITORS IN ADVANCED MELANOMA ACROSS EU5
    Rider, A.
    Lewis, K.
    Higson, O.
    VALUE IN HEALTH, 2018, 21 : S56 - S57
  • [49] UTILITY OF REAL WORLD EVIDENCE DATA TO SUPPORT MARKET ACCESS OF RARE ONCOLOGY INDICATIONS IN EU5
    Kumar, P.
    VALUE IN HEALTH, 2019, 22 : S857 - S857
  • [50] MANAGEMENT OF OSTEOGENESIS IMPERFECTA: SELFREPORTED FUNDING SOURCES FOR HEALTHCARE, CONSUMABLES AND SERVICES ACROSS THE EU5 AND NORDICS
    Wekre, L. L.
    Westerheim, I
    van Welzenis, T.
    Raggio, C.
    Bober, M. B.
    Hart, T.
    Semler, O.
    Dadzie, R.
    Rapoport, M.
    Prince, S.
    Rauch, F.
    VALUE IN HEALTH, 2023, 26 (12) : S497 - S498
12345